This study aimed to evaluate the role of alveolar macrophages (AMs) in the internalisation and early clearance of Pseudomonas aeruginosa in the lung. AMs were depleted by intranasal administration of liposome-encapsulated clodronate disodium. At 24 h following the instillation of liposomes, a sublethal dose of P. aeruginosa (1 X 104 cfu) was inoculated intratracheally. Lung tissue was then evaluated for survival, viable bacteria and for histopathology 4 and 24 h post-infection. AM depletion of 90% did not affect the survival rate of infected mice but the clearance of P. aeruginosa was reduced at 24 h (P<0.05). While at 4 h AM-depleted and control mice showed similar level of PMN recruitment in the distal lung, 24 h post-infection tickening ...
Accès full text sur le site de l'éditeur http://www.jimmunol.org/cgi/content/full/181/1/586Acute lun...
RATIONALE: Antimicrobial resistance challenges therapy of pneumonia. Enhancing macrophage microbicid...
A. A strategy designed for mice challenge with P. aeruginosa via an intranasal administration. As de...
The objective of this study was to evaluate the role of alveolar macrophages (AM) in clearance of P...
The role of alveolar macrophages (AM) in host defense against pulmonary infection has been difficult...
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious respiratory disease in the i...
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious respiratory disease in the i...
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious respiratory disease in the i...
Alveolar macrophages (AMs) are considered major effector cells in host defense against respiratory t...
Pseudomonas aeruginosa is a leading cause of pneumonia, and many components of the innate immune sys...
Pseudomonas aeruginosa is a leading cause of pneumonia, and many components of the innate immune sys...
Indirect evidence suggests that innate immune mechanisms involving alveolar macrophages (AMs) are of...
120 CFU being lethal. Activation of a MyD88-independent pathway for PMN recruitment to the lungs in ...
Pathogen persistence in the respiratory tract is an important preoccupation, and of particular relev...
Rationalle: antimicrobial resistance challenges therapy of pneumonia. Enhancing macrophage microbici...
Accès full text sur le site de l'éditeur http://www.jimmunol.org/cgi/content/full/181/1/586Acute lun...
RATIONALE: Antimicrobial resistance challenges therapy of pneumonia. Enhancing macrophage microbicid...
A. A strategy designed for mice challenge with P. aeruginosa via an intranasal administration. As de...
The objective of this study was to evaluate the role of alveolar macrophages (AM) in clearance of P...
The role of alveolar macrophages (AM) in host defense against pulmonary infection has been difficult...
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious respiratory disease in the i...
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious respiratory disease in the i...
Pseudomonas aeruginosa is an opportunistic pathogen that causes serious respiratory disease in the i...
Alveolar macrophages (AMs) are considered major effector cells in host defense against respiratory t...
Pseudomonas aeruginosa is a leading cause of pneumonia, and many components of the innate immune sys...
Pseudomonas aeruginosa is a leading cause of pneumonia, and many components of the innate immune sys...
Indirect evidence suggests that innate immune mechanisms involving alveolar macrophages (AMs) are of...
120 CFU being lethal. Activation of a MyD88-independent pathway for PMN recruitment to the lungs in ...
Pathogen persistence in the respiratory tract is an important preoccupation, and of particular relev...
Rationalle: antimicrobial resistance challenges therapy of pneumonia. Enhancing macrophage microbici...
Accès full text sur le site de l'éditeur http://www.jimmunol.org/cgi/content/full/181/1/586Acute lun...
RATIONALE: Antimicrobial resistance challenges therapy of pneumonia. Enhancing macrophage microbicid...
A. A strategy designed for mice challenge with P. aeruginosa via an intranasal administration. As de...